Xianchi Dong

2.3k citations
35 papers · 1.6k indexed · 1 hit paper · h-index 20

Xianchi Dong

35 papers receiving 1.5k citations

Hit Papers

N501Y mutation of spike protein in SARS-CoV-2 strengthens...243202120262022202450100150200

Peers

Xianchi Dong
Comparison fields: 5 of 97
  • Immunology and Allergy 296
  • Infectious Diseases 286
  • Hematology 164
  • Immunology 266
  • Molecular Biology 808
Replace John E. Pak with:
John E. Pak United States
Sarah Schmidt Germany
Octavio Miguel Rivero-Lezcano Spain
Esther M. Lafuente Spain
Mónica Gordón‐Alonso Spain
Mark Champe United States
Anu Cherukuri United States
Lynda M. Pierini United States
Padmaja Mehta United States
R. Crowther United States
Xianchi Dong relative to John E. Pak United States John E. Pak's profile →
Citations per field
00.5×
John E. Pak · 1×
Citations per year

Countries citing papers authored by Xianchi Dong

Since Specialization
Citations

This map shows the geographic impact of Xianchi Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianchi Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianchi Dong more than expected).

Fields of papers citing papers by Xianchi Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianchi Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianchi Dong. The network helps show where Xianchi Dong may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Xianchi Dong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xianchi Dong Line = papers co-authored together Xianchi Dong links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20241
3 20243
4 20223
5 201956
6 201736
7 2017208
8 201769
9 201458
10 2014114
11 20117
12 201016
13 200914
14 200956
15 200853
16 200835
17 2006122
18 20063
19 200619
20 20058

About Xianchi Dong

Xianchi Dong is a scholar working on Immunology and Allergy, Health Informatics and Family Practice, having authored 35 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (10 papers), Platelet Disorders and Treatments (5 papers), Cellular Mechanics and Interactions (4 papers), RNA and protein synthesis mechanisms (4 papers), Complement system in diseases (3 papers), Protease and Inhibitor Mechanisms (3 papers), Lipid Membrane Structure and Behavior (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). The work is most often cited by research in Immunology and Allergy (296 citations), Infectious Diseases (286 citations) and Hematology (164 citations). Xianchi Dong has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Timothy A. Springer, Chafen Lu, Jianghai Zhu, Jianping Ding, Bo Zhao, Bei Tong, Bin Zheng, Peng Zheng, F. Tian and Zibin Wang. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026